A Facebook promo for a session from The Pioneers on peptide use among bodybuilders, with few details on who speaks or what claims get made.
Recap by typeshit. Post by Facebook on Facebook.
The MFDS approval rests on SURPASS-CVOT, where Mounjaro matched Trulicity on heart events in 13,000+ patients but did not prove superior.
Inside Retail Asia looks at skincare and aesthetic treatments brands are building for facial volume loss after rapid weight loss.
The actor told an interviewer people can take Ozempic carefree, while stressing that nothing replaces actually working out.
CFO MV Narasimham says the company still expects to ship 6 to 7 million pens across 10 approved markets between November and March, with Canada taking most of them.
EMY says a newer class of weight loss drugs is beating Ozempic. The drugs and the data behind the claim are not named, so tap through for the details.
An investor take on Indian contract manufacturers: the argument is that spending on plants for peptides, ADCs and oligos matters more than concall buzz.
Loading…